SymBiosis Capital Partners, LLC - 13 Nov 2025 SCHEDULE 13G Report for Rani Therapeutics Holdings, Inc. Class A Common Stock

Filing Manager: SymBiosis Capital Partners, LLC
Reporting Manager: SymBiosis Capital Partners, LLC
Security: Rani Therapeutics Holdings, Inc. Class A Common Stock
Shares outstanding: 96,923,077 shares
Disclosed Ownership: 6,300,000 shares
Ownership: 6.5%
Form type: SCHEDULE 13G
Filing time: 12 Feb 2026, 13:45:24 UTC
Date of event: 13 Nov 2025
SEC: View on sec.gov

Reporting Managers (1)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
SymBiosis Capital Partners, LLC	6.5%	6,300,000	6,300,000	0	/s/ Chidozie Ugwumba	Managing Partner